Safety and efficacy of azacitidine in the treatment of elderly patients with myelodysplastic syndrome
about
Trials with 'epigenetic' drugs: an updatePlatelet response during the second cycle of decitabine treatment predicts response and survival for myelodysplastic syndrome patients.Managing myelodysplastic syndromes in very old patients: a teaching case report.Drugging the pain epigenome.Downregulation of HO-1 promoted apoptosis induced by decitabine via increasing p15INK4B promoter demethylation in myelodysplastic syndrome.A retrospective study of azacitidine treatment in patients with intermediate-2 or high risk myelodysplastic syndromes in a real-world clinical setting in Greece.Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic Syndromes.Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome : a retrospective study from The Korean Society of Hematology AML/MDS Working Party.
P2860
Q27000542-D8C39D24-9E2D-4376-AFD8-D2E7BF386A3DQ36140902-7E0EEB38-AC5F-4310-AF93-C15C0EBC5262Q36772626-7C9C676E-B90C-451B-B343-D87F375F1EA6Q38761806-7E56989A-4895-4995-9A50-E1A0F39C7FBDQ38912946-887B476D-B931-42D1-B568-C9B32C1AFD88Q38999351-208AA4BE-5D8B-43AE-AC8C-AF08E1CA630AQ43558574-42D2EE63-13C7-423F-AEDC-E0EB538E24E3Q45624632-F3075A66-99B1-4D97-814B-F4E38DFFCC41
P2860
Safety and efficacy of azacitidine in the treatment of elderly patients with myelodysplastic syndrome
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Safety and efficacy of azaciti ...... with myelodysplastic syndrome
@ast
Safety and efficacy of azaciti ...... with myelodysplastic syndrome
@en
Safety and efficacy of azaciti ...... with myelodysplastic syndrome
@nl
type
label
Safety and efficacy of azaciti ...... with myelodysplastic syndrome
@ast
Safety and efficacy of azaciti ...... with myelodysplastic syndrome
@en
Safety and efficacy of azaciti ...... with myelodysplastic syndrome
@nl
prefLabel
Safety and efficacy of azaciti ...... with myelodysplastic syndrome
@ast
Safety and efficacy of azaciti ...... with myelodysplastic syndrome
@en
Safety and efficacy of azaciti ...... with myelodysplastic syndrome
@nl
P2860
P921
P356
P1476
Safety and efficacy of azaciti ...... with myelodysplastic syndrome
@en
P2093
Ellen K Ritchie
P2860
P304
P356
10.2147/CIA.S24659
P407
P577
2012-06-19T00:00:00Z